NCT06359236

Brief Summary

The primary purpose of this project is to observe the effects of Cognitive Behavioral Psychotherapy-based weight-loss mobile application (Bi' Kilo) in 4 essential areas (Anthropometric, Biochemical, Psychometric, Cognitive) in overweight and obese individuals and to test whether these effects will persist after ten weeks. In this context, the original value of the proposed study is that a mobile application will be produced that is suitable for the culture and whose effectiveness has been scientifically proven. In our current project proposal, the measurements of the participants will be evaluated holistically together with both tests and inventories, as well as physical measurements and biochemical data. In this study, the usability of the mobile application to be developed will also be evaluated and reported. The study group of the research will consist of overweight and obese individuals. The first stage will be a pilot study to identify the shortcomings of the Bi'Kilo mobile application. After eliminating the deficiencies of the Bi' Kilo mobile application, a working group will be formed in the second phase of the research. At this stage, the sample will be divided into two different groups within the scope of the study and a study group and a control group will be formed. The study consists of three phases as preparation, implementation, and follow-up. Measurements of the participants will be made at the beginning (Anthropometric, Biochemical, Psychometric, Cognitive), at the end of the six-week implementation phase (Anthropometric), and at the end of the four-week follow-up phase (Anthropometric, Biochemical, Psychometric, Cognitive).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2022

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 11, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2024

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2024

Enrollment Period

2 years

First QC Date

March 6, 2024

Last Update Submit

April 13, 2025

Conditions

Keywords

cognitive behavioral therapye-health applicationsobesityweight control

Outcome Measures

Primary Outcomes (1)

  • Body Mass Index (BMI)

    Body Mass Index is a person's weight in kilograms divided by the square of height in meters.

    Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)

Secondary Outcomes (20)

  • Weight

    Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)

  • Height

    Pre-test

  • Waist Circumference (WC)

    Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)

  • Hip Circumference

    Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)

  • Waist-Hip Ratio (WHR)

    Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)

  • +15 more secondary outcomes

Other Outcomes (5)

  • Demographic Information Form

    Pre-test

  • Structured Clinical Interview for DSM-5 Disorders (SCID-5)

    Pre-test

  • The Eating Disorder Assessment for DSM-5 (EDA-5)

    Pre-test

  • +2 more other outcomes

Study Arms (2)

Treatment Group

EXPERIMENTAL

Participants in the treatment group will be involved in a process that includes three phases of the study: preparation phase, implementation phase and follow-up phase.

Other: BI'KILO Intervention

Control Group

NO INTERVENTION

The control group will not be able to access the entire treatment program content. However, they will be able to access animation contents such as energy balance training, eating change, planning where and when and what to eat, healthy weight loss targets, three main and three snacks, determining weight loss targets and informational content titled diet types specified in the nutrition education module for a period of 6 weeks.

Interventions

The study consists of three stages: preparation phase, implementation phase and follow-up phase. During the preparation phase, participants' weight and body fat ratio will be calculated using a body analysis scale, and their height, waist and hip circumference will be measured. The implementation phase will last six weeks and consists of six modules, each lasting one week. The skills and practices aimed to be acquired in each module will be required to be applied in the following practice modules. At the end of the implementation phase, participants' weight, waist and hip circumferences will be measured again. The final phase, called the follow-up phase, will last four weeks. During this phase, participants will continue to keep a self-monitoring record of their eating and physical exercise, complete a hunger scale, and application card notifications will continue to be displayed.

Treatment Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • volunteering to participate in the study
  • being literate
  • being overweight
  • being over the age of 18

You may not qualify if:

  • Being diagnosed with substance and/or alcohol use disorder
  • being illiterate
  • Being pregnant or having a pregnancy plan during the research period
  • Being diagnosed with a disease that causes neuroendocrine obesity (Cushing's disease, hypothyroidism, hypothalamic obesity, growth hormone deficiency, hypogonadism, pseudohypoparathyroidism, polycystic ovary syndrome)
  • Using antipsychotics, antiobesity drugs or cortisone-containing drugs
  • Being a cigarette-smoker
  • If the participant withdraws his/her consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eskisehir Osmangazi University Faculty of Medicine

Eskişehir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Weight LossObesityOverweightFeeding Behavior

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBehavior, AnimalBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. of Psychiatry

Study Record Dates

First Submitted

March 6, 2024

First Posted

April 11, 2024

Study Start

July 15, 2022

Primary Completion

July 15, 2024

Study Completion

September 15, 2024

Last Updated

April 16, 2025

Record last verified: 2024-04

Locations